Alzheimer's

What research is conducted by the NIA?

The NIA, one of the 27 Institutes and Centers of NIH, leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. The NIA supports and conducts genetic, biological, clinical, behavioral, social, and economic research related to the aging process, diseases and conditions associated with aging, and other special problems and needs of older Americans. The NIA is the primary Federal agency for research on Alzheimer’s disease. To learn more about the NIA, visit www.nia.nih.gov/about.

My family member has just been diagnosed with Alzheimer’s disease. What should I do?

Visit www.alzheimers.gov, the Federal government’s gateway to reliable, comprehensive information about Alzheimer’s disease from Federal, State, and private organizations.

How can I find information about local support groups for people with Alzheimer’s disease and their caregivers?

The Alzheimer’s Disease Education and Referral (ADEAR) Center offers free resources for people with Alzheimer’s disease and caregivers, as well as referrals to helpful organizations.
1-800-438-4380 (toll-free)
www.nia.nih.gov/alzheimers

You can also contact the following organizations for more information:

Dallas W. Anderson, Ph.D.

Dr. Anderson joined the NIA in 2003 and serves as a program administrator in the Dementias of Aging Branch, Division of Neuroscience. He manages the grant portfolio pertaining to the epidemiology of Alzheimer’s disease and other age-related cognitive impairment. Before coming to NIA, Dr. Anderson worked for many years in the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, where he headed a population studies unit and conducted research in the field of neuroepidemiology. Dr. Anderson holds A.B. (Mathematics), M.P.H.

AD Translational Initiatives

Neuroimaging in the Diagnosis of Alzheimer's Disease and Dementia

The DN convened this exploratory meeting in conjunction with the Center for Medicaid and Medicare Services to explore the status of various neuroimaging technologies (magnetic resonance imaging, positron emission tomography, and single photon emission spectroscopy) in the diagnosis of mild cognitive impairment and Alzheimer's disease.

NIA Virtual Repository

Subscribe to RSS - Alzheimer's